USD 0.88
(-2.65%)
Year | Long Term Debt | Long Term Debt Growth |
---|---|---|
2023 | 6.53 Million USD | -11.36% |
2022 | 7.36 Million USD | -8.61% |
2021 | 8.06 Million USD | -96.73% |
2020 | 246.37 Million USD | 20.9% |
2019 | 203.77 Million USD | 177.7% |
2018 | 73.38 Million USD | 0.0% |
2017 | - USD | 0.0% |
2016 | - USD | 0.0% |
2015 | - USD | 0.0% |
2014 | - USD | 0.0% |
2013 | - USD | -100.0% |
2012 | 3.58 Million USD | 0.0% |
2011 | - USD | 0.0% |
2010 | - USD | 0.0% |
2009 | - USD | 0.0% |
2008 | - USD | 0.0% |
2007 | - USD | 0.0% |
2006 | - USD | -100.0% |
2005 | 58.82 Thousand USD | 0.0% |
2004 | - USD | 0.0% |
2003 | - USD | 0.0% |
2002 | - USD | 0.0% |
2001 | - USD | 0.0% |
2000 | - USD | 0.0% |
1999 | - USD | 0.0% |
1998 | - USD | 0.0% |
1997 | - USD | 0.0% |
1996 | - USD | 0.0% |
1995 | - USD | 0.0% |
1994 | - USD | 0.0% |
Year | Long Term Debt | Long Term Debt Growth |
---|---|---|
2024 Q1 | 6.31 Million USD | -100.0% |
2024 Q2 | 6 Million USD | 0.0% |
2023 Q2 | 6.93 Million USD | -2.75% |
2023 FY | 6.53 Million USD | -11.36% |
2023 Q1 | 7.13 Million USD | -3.18% |
2023 Q3 | 6.74 Million USD | -2.87% |
2023 Q4 | 6.53 Million USD | -3.09% |
2022 Q4 | 7.36 Million USD | -2.44% |
2022 Q3 | 7.55 Million USD | -2.26% |
2022 Q2 | 7.72 Million USD | -2.14% |
2022 FY | 7.36 Million USD | -8.61% |
2022 Q1 | 7.89 Million USD | -2.06% |
2021 Q2 | 183.64 Million USD | -2.06% |
2021 FY | 8.06 Million USD | -96.73% |
2021 Q3 | 179.96 Million USD | -2.0% |
2021 Q1 | 187.5 Million USD | -23.9% |
2021 Q4 | 8.06 Million USD | -95.52% |
2020 Q2 | 253.1 Million USD | 0.36% |
2020 Q1 | 252.21 Million USD | 23.77% |
2020 Q3 | 245.95 Million USD | -2.82% |
2020 Q4 | 246.37 Million USD | 0.17% |
2020 FY | 246.37 Million USD | 20.9% |
2019 Q2 | 196.58 Million USD | 157.9% |
2019 FY | 203.77 Million USD | 177.7% |
2019 Q1 | 76.22 Million USD | 3.88% |
2019 Q4 | 203.77 Million USD | -0.04% |
2019 Q3 | 203.86 Million USD | 3.7% |
2018 Q2 | 73.14 Million USD | 0.0% |
2018 Q3 | 73.26 Million USD | 0.16% |
2018 Q4 | 73.38 Million USD | 0.16% |
2018 Q1 | - USD | 0.0% |
2018 FY | 73.38 Million USD | 0.0% |
2017 FY | - USD | 0.0% |
2017 Q4 | - USD | 0.0% |
2017 Q1 | - USD | 0.0% |
2017 Q2 | - USD | 0.0% |
2017 Q3 | - USD | 0.0% |
2016 FY | - USD | 0.0% |
2016 Q1 | - USD | 0.0% |
2016 Q2 | - USD | 0.0% |
2016 Q3 | - USD | 0.0% |
2016 Q4 | - USD | 0.0% |
2015 Q2 | - USD | 0.0% |
2015 Q3 | - USD | 0.0% |
2015 Q4 | - USD | 0.0% |
2015 Q1 | - USD | 0.0% |
2015 FY | - USD | 0.0% |
2014 Q2 | - USD | 0.0% |
2014 FY | - USD | 0.0% |
2014 Q1 | - USD | 0.0% |
2014 Q3 | - USD | 0.0% |
2014 Q4 | - USD | 0.0% |
2013 Q4 | - USD | 0.0% |
2013 FY | - USD | -100.0% |
2013 Q3 | - USD | 0.0% |
2013 Q2 | - USD | 0.0% |
2013 Q1 | - USD | -100.0% |
2012 Q2 | 3.09 Million USD | 39.92% |
2012 FY | 3.58 Million USD | 0.0% |
2012 Q1 | 2.21 Million USD | 0.0% |
2012 Q3 | 3.34 Million USD | 8.0% |
2012 Q4 | 3.58 Million USD | 7.41% |
2011 FY | - USD | 0.0% |
2011 Q4 | - USD | 0.0% |
2011 Q3 | - USD | 0.0% |
2011 Q2 | - USD | 0.0% |
2011 Q1 | - USD | 0.0% |
2010 Q2 | - USD | 0.0% |
2010 FY | - USD | 0.0% |
2010 Q3 | - USD | 0.0% |
2010 Q4 | - USD | 0.0% |
2010 Q1 | - USD | 0.0% |
2009 FY | - USD | 0.0% |
2009 Q3 | - USD | 0.0% |
2009 Q2 | - USD | 0.0% |
2009 Q4 | - USD | 0.0% |
2009 Q1 | - USD | 0.0% |
2008 Q2 | - USD | 0.0% |
2008 Q1 | - USD | 0.0% |
2008 FY | - USD | 0.0% |
2008 Q4 | - USD | 0.0% |
2008 Q3 | - USD | 0.0% |
2007 Q3 | - USD | 0.0% |
2007 Q1 | - USD | 0.0% |
2007 Q2 | - USD | 0.0% |
2007 FY | - USD | 0.0% |
2007 Q4 | - USD | 0.0% |
2006 Q4 | - USD | -100.0% |
2006 Q3 | 63.22 Thousand USD | 2.38% |
2006 FY | - USD | -100.0% |
2006 Q2 | 61.76 Thousand USD | 2.43% |
2006 Q1 | 60.29 Thousand USD | 2.49% |
2005 Q4 | 58.82 Thousand USD | 4.53% |
2005 Q1 | - USD | 0.0% |
2005 FY | 58.82 Thousand USD | 0.0% |
2005 Q3 | 56.28 Thousand USD | 0.0% |
2005 Q2 | - USD | 0.0% |
2004 Q3 | - USD | 0.0% |
2004 Q1 | - USD | 0.0% |
2004 Q2 | - USD | 0.0% |
2004 FY | - USD | 0.0% |
2004 Q4 | - USD | 0.0% |
2003 Q3 | - USD | 0.0% |
2003 Q4 | - USD | 0.0% |
2003 Q2 | - USD | 0.0% |
2003 Q1 | - USD | 0.0% |
2003 FY | - USD | 0.0% |
2002 Q1 | - USD | 0.0% |
2002 Q4 | - USD | 0.0% |
2002 Q3 | - USD | 0.0% |
2002 Q2 | - USD | 0.0% |
2002 FY | - USD | 0.0% |
2001 Q4 | - USD | 0.0% |
2001 Q1 | - USD | 0.0% |
2001 FY | - USD | 0.0% |
2001 Q2 | - USD | 0.0% |
2001 Q3 | - USD | 0.0% |
2000 Q4 | - USD | 0.0% |
2000 Q3 | - USD | 0.0% |
2000 Q2 | - USD | 0.0% |
2000 Q1 | - USD | 0.0% |
2000 FY | - USD | 0.0% |
1999 Q4 | - USD | 0.0% |
1999 FY | - USD | 0.0% |
1998 FY | - USD | 0.0% |
1997 FY | - USD | 0.0% |
1996 FY | - USD | 0.0% |
1995 FY | - USD | 0.0% |
1994 FY | - USD | 0.0% |
Name | Long Term Debt | Long Term Debt Difference |
---|---|---|
Journey Medical Corporation | 14.62 Million USD | 55.328% |
ANI Pharmaceuticals, Inc. | 309.66 Million USD | 97.891% |
Aquestive Therapeutics, Inc. | 91.07 Million USD | 92.828% |
Pacira BioSciences, Inc. | 513.79 Million USD | 98.729% |
Sunshine Biopharma, Inc. | 539.03 Thousand USD | -1111.795% |
Sunshine Biopharma, Inc. | 539.03 Thousand USD | -1111.795% |
SCYNEXIS, Inc. | 12.15 Million USD | 46.278% |
Safety Shot Inc | 304.9 Thousand USD | -2042.293% |
Alpha Teknova, Inc. | 13.25 Million USD | 50.706% |
Collegium Pharmaceutical, Inc. | 489.96 Million USD | 98.667% |
Bright Green Corporation | 201.78 Thousand USD | -3137.141% |
Dynavax Technologies Corporation | 252.41 Million USD | 97.412% |
Esperion Therapeutics, Inc. | 501.54 Million USD | 98.698% |
Cosmos Health Inc. | 3.03 Million USD | -115.198% |
PainReform Ltd. | 30 Thousand USD | -21673.333% |
China SXT Pharmaceuticals, Inc. | 117.12 Thousand USD | -5476.757% |
Embecta Corp. | 1.62 Billion USD | 99.598% |
Intra-Cellular Therapies, Inc. | 13.32 Million USD | 50.983% |
Procaps Group, S.A. | 28.41 Million USD | 77.008% |
Theratechnologies Inc. | 51.26 Million USD | 87.257% |
Harrow Health, Inc. | 183.17 Million USD | 96.434% |
Sonoma Pharmaceuticals, Inc. | 87 Thousand USD | -7408.046% |
Biofrontera Inc. | 804 Thousand USD | -712.438% |
DURECT Corporation | 2.7 Million USD | -141.747% |
Supernus Pharmaceuticals, Inc. | 33.19 Million USD | 80.323% |
Cronos Group Inc. | 1.55 Million USD | -318.987% |
OptiNose, Inc. | 611 Thousand USD | -969.067% |
Ironwood Pharmaceuticals, Inc. | 498.3 Million USD | 98.689% |
Kala Pharmaceuticals, Inc. | 34.19 Million USD | 80.895% |
RedHill Biopharma Ltd. | 455 Thousand USD | -1335.604% |
Organogenesis Holdings Inc. | 60.74 Million USD | 89.247% |
Guardion Health Sciences, Inc. | - USD | -Infinity% |
Cumberland Pharmaceuticals Inc. | 12.78 Million USD | 48.905% |
Radius Health, Inc. | 339.66 Million USD | 98.077% |
Universe Pharmaceuticals INC | - USD | -Infinity% |
ProPhase Labs, Inc. | 10.25 Million USD | 36.323% |
Phibro Animal Health Corporation | 458.28 Million USD | 98.575% |
Procaps Group S.A. | 28.41 Million USD | 77.008% |
Alvotech | 1.02 Billion USD | 99.364% |
Viatris Inc. | 16.18 Billion USD | 99.96% |
Rockwell Medical, Inc. | 8.29 Million USD | 21.235% |
Aytu BioPharma, Inc. | 10.87 Million USD | 39.947% |
SIGA Technologies, Inc. | 335.99 Thousand USD | -1844.1% |
Tilray Brands, Inc. | 287.93 Million USD | 97.731% |
Lifecore Biomedical, Inc. | 120.51 Million USD | 94.58% |
Shineco, Inc. | 10.01 Million USD | 34.793% |
PetIQ, Inc. | 437.82 Million USD | 98.508% |
Regencell Bioscience Holdings Limited | - USD | -Infinity% |
Incannex Healthcare Limited | 210 Thousand USD | -3010.476% |
Neurocrine Biosciences, Inc. | 258.3 Million USD | 97.471% |
Alimera Sciences, Inc. | 64.48 Million USD | 89.871% |
Silver Spike Investment Corp. | - USD | -Infinity% |
Assertio Holdings, Inc. | 38.51 Million USD | 83.04% |
Shuttle Pharmaceuticals Holdings, Inc. | 135.08 Thousand USD | -4735.331% |
Petros Pharmaceuticals, Inc. | 6.85 Million USD | 4.745% |
Clever Leaves Holdings Inc. | 720 Thousand USD | -807.222% |
Cyclo Therapeutics, Inc. | 22.48 Thousand USD | -28951.77% |
Avadel Pharmaceuticals plc | 32.75 Million USD | 80.061% |
Hempacco Co., Inc. | 5.93 Million USD | -10.133% |
Talphera, Inc. | - USD | -Infinity% |
Alvotech | 1.02 Billion USD | 99.364% |
Eagle Pharmaceuticals, Inc. | 56.21 Million USD | 88.381% |
Lantheus Holdings, Inc. | 616.12 Million USD | 98.94% |
Currenc Group, Inc. | 2.5 Million USD | -160.553% |
Kamada Ltd. | 7.43 Million USD | 12.181% |
Indivior PLC | 235.66 Million USD | 97.228% |
Evoke Pharma, Inc. | 5 Million USD | -30.64% |
Flora Growth Corp. | 942 Thousand USD | -593.418% |
Cyclo Therapeutics, Inc. | 22.48 Thousand USD | -28951.77% |
Evolus, Inc. | 120.35 Million USD | 94.573% |
HUTCHMED (China) Limited | 48.18 Million USD | 86.445% |
Amphastar Pharmaceuticals, Inc. | 589.19 Million USD | 98.891% |
Akanda Corp. | 2.49 Million USD | -161.578% |